About: http://webisa.webdatacommons.org/38548934

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Therefore, although natalizumab and other antibody immunotherapies seem poised to markedly enhance our treatment of MS, more data is required before we know exactly where this class of medications belongs in the arsenal.
http://www.w3.org/ns/prov#wasQuotedFrom	thisisms.com